Pricing Log in Create free account

MiMedx Group, Inc (MDXG) vs Ovid Therapeutics (OVID)

MiMedx Group, Inc and Ovid Therapeutics are both Biotechnology companies. MiMedx Group, Inc and Ovid Therapeutics are of similar size ($503.9M and $478.6M). Ovid Therapeutics grew revenue faster over the last twelve months: 1,333.4% against −22.8%. MiMedx Group, Inc has the higher net margin (−6.32% vs −439.1%) and the higher return on invested capital (−17.4% vs −35.1%). Across the 18 metrics below, MiMedx Group, Inc leads on 14 and Ovid Therapeutics on 4.

Valuation

Metric MDXG OVID Biotechnology median
P/E n/m n/m 10.60
P/S 1.59 72.14 9.40
P/B 2.29 2.70 2.13
Price to free cash flow 25.38 n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales 1.25 58.65 9.02
Earnings yield (3.91%) (7.85%) (32.88%)
Free cash flow yield 3.94% (9.69%) (23.13%)

Profitability

Metric MDXG OVID Biotechnology median
Gross margin 77.29% 100.00% 68.51%
Operating margin (8.28%) (742.97%) 0.00%
Net margin (6.32%) (439.11%) 0.00%
Free cash flow margin 6.26% (697.30%) 0.00%
Return on equity (8.53%) (25.97%) (51.96%)
Return on assets (6.58%) (22.30%) (46.06%)
Return on invested capital (17.40%) (35.11%) 0.00%

Growth

Metric MDXG OVID Biotechnology median
Revenue growth (TTM) (22.80%) 1,333.39% 6.76%
EPS growth (last fiscal year) 14.29% 37.84% 29.88%
Revenue growth, 5-year CAGR 11.02% (10.48%) 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric MDXG OVID Biotechnology median
Debt to equity 0.00 0.05 0.00
Current ratio 4.35 12.39 4.97
Net debt to EBITDA (1.88) 1.37 1.01

Dividend

Metric MDXG OVID Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric MDXG OVID Biotechnology median
Market cap 478.63m 503.87m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack